ATE336488T1 - Neue ortho-naphthochinonderivate, neue synthesen zu ihrer herstellung und ihre anwendung in der inhibierung von neoplastischem zellwachstum - Google Patents

Neue ortho-naphthochinonderivate, neue synthesen zu ihrer herstellung und ihre anwendung in der inhibierung von neoplastischem zellwachstum

Info

Publication number
ATE336488T1
ATE336488T1 AT97907860T AT97907860T ATE336488T1 AT E336488 T1 ATE336488 T1 AT E336488T1 AT 97907860 T AT97907860 T AT 97907860T AT 97907860 T AT97907860 T AT 97907860T AT E336488 T1 ATE336488 T1 AT E336488T1
Authority
AT
Austria
Prior art keywords
new
naphthochinone
inhibition
derivatives
production
Prior art date
Application number
AT97907860T
Other languages
English (en)
Inventor
Benjamin J Frydman
Donald T Witiak
Laurence J Marton
Karen Neder
Eileen M Dolan
Andrew H Geiser
Jerry Shunneng Sun
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/604,131 external-priority patent/US5824700A/en
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Application granted granted Critical
Publication of ATE336488T1 publication Critical patent/ATE336488T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/92—Naphthopyrans; Hydrogenated naphthopyrans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT97907860T 1996-02-20 1997-02-20 Neue ortho-naphthochinonderivate, neue synthesen zu ihrer herstellung und ihre anwendung in der inhibierung von neoplastischem zellwachstum ATE336488T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/604,131 US5824700A (en) 1996-02-20 1996-02-20 Ortho-quinone derivatives novel synthesis therefor and their use in the inhibition of neoplastic cell growth
US08/744,631 US5883270A (en) 1996-02-20 1996-11-06 4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growth

Publications (1)

Publication Number Publication Date
ATE336488T1 true ATE336488T1 (de) 2006-09-15

Family

ID=27084594

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97907860T ATE336488T1 (de) 1996-02-20 1997-02-20 Neue ortho-naphthochinonderivate, neue synthesen zu ihrer herstellung und ihre anwendung in der inhibierung von neoplastischem zellwachstum

Country Status (7)

Country Link
US (2) US5883270A (de)
EP (1) EP0888326B1 (de)
JP (1) JP2000506841A (de)
AT (1) ATE336488T1 (de)
AU (1) AU1975497A (de)
DE (1) DE69736515D1 (de)
WO (1) WO1997031936A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
EP1574507A3 (de) * 1999-04-30 2005-10-26 SLIL Biomedical Corporation Furo- und Pyrano-Naphthochinone und ihre Verwendung gegen Krebs
WO2000066175A2 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Conjugates as therapies for cancer and prostate diseases
US6482943B1 (en) * 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
WO2000066528A2 (en) * 1999-04-30 2000-11-09 Slil Biomedical Corporation Quinones for treatment of diseases
US6939896B2 (en) * 1999-12-21 2005-09-06 Astrazeneca Ab Cd45 inhibitors
DE60023744T2 (de) * 1999-12-21 2006-09-21 Astrazeneca Ab Cd45 inhibitoren
CA2428425A1 (en) * 2000-11-07 2002-08-01 Dana-Farber Cancer Institute, Inc. Method of treating hematologic tumors and cancers
US7070797B2 (en) 2000-11-07 2006-07-04 Dana Farber Cancer Institute, Inc. Method of treating hematologic tumors and cancers
EP1337504A4 (de) * 2000-11-08 2005-10-05 Cellgate Inc Neue polyaminanalogon-aminosäure-konjugate zur verwendung als krebsmittel
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
KR100455458B1 (ko) * 2001-10-18 2004-11-08 (주)바이오니아 1,2-나프토퀴논유도체 및 약학적으로 허용되는 이들의염과 그 제조방법
WO2003090710A1 (en) * 2002-04-23 2003-11-06 Case Western Reserve University Lapachone delivery systems, compositions and uses related thereto
EP1567515A4 (de) * 2002-11-18 2008-04-23 Arqule Inc Neue lapachonverbindungen und verfahren zu deren anwendung
WO2005082358A2 (en) * 2004-02-20 2005-09-09 Arqule, Inc. Use of beta-lapachone as a broad spectrum anti-cancer agent
WO2014018919A1 (en) * 2012-07-27 2014-01-30 The Regents Of The University Of California Seriniquinones, melanoma-specific anticancer agents
CN105130936B (zh) * 2015-09-01 2017-09-26 中国药科大学 一类邻萘醌化合物、其制备方法和医药用途
US10829427B2 (en) 2015-12-18 2020-11-10 The Board Of Regents Of The University Of Texas System Naphthoquinones, pro-drugs, and methods of use thereof
CN111867580B (zh) 2018-01-18 2023-05-26 （株）娜迪安生物公司 用于预防或改善脱发的包含有效成分董尼酮的组合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879243A (en) * 1987-05-26 1989-11-07 Eastman Kodak Company Use of substituted ortho-quinones as electron transfer agents in analytical determinations
US4882339A (en) * 1987-07-10 1989-11-21 Ciba-Geigy Corporation 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals
LU87403A1 (fr) * 1988-12-06 1990-07-10 Oreal Procede de teinture de fibres keratiniques avec un hydroxyindole,associe a un derive quinonique
DE3926747A1 (de) * 1989-08-12 1991-02-14 Basf Ag 1,2-napthochinone enthaltende fungizide mittel
GB9216859D0 (en) * 1992-08-07 1992-09-23 Wellcome Found Medicaments
EP0659190A1 (de) * 1992-11-09 1995-06-28 Biochem Pharma Inc Antineoplastic heteronaphtochinone
AU6672794A (en) * 1993-11-05 1995-05-23 Biochem Pharma Inc. Antineoplastic heteronaphthoquinones
US5763625A (en) * 1995-04-25 1998-06-09 Wisconsin Alumni Research Foundation Synthesis and use of β-lapachone analogs

Also Published As

Publication number Publication date
DE69736515D1 (de) 2006-09-28
WO1997031936A2 (en) 1997-09-04
EP0888326A2 (de) 1999-01-07
US5883270A (en) 1999-03-16
AU1975497A (en) 1997-09-16
JP2000506841A (ja) 2000-06-06
WO1997031936A3 (en) 1998-01-08
EP0888326B1 (de) 2006-08-16
US5977187A (en) 1999-11-02

Similar Documents

Publication Publication Date Title
ATE336488T1 (de) Neue ortho-naphthochinonderivate, neue synthesen zu ihrer herstellung und ihre anwendung in der inhibierung von neoplastischem zellwachstum
SE9504661D0 (sv) New compounds
ATE264692T1 (de) Verwendung von no synthase hemmern und fängern von reaktiven sauerstoffsformen zur behandlung von ischämie
MY119483A (en) 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistant cancer cell sensitizers
DE59209907D1 (de) Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln
TR199902626T2 (xx) Enflamasyon tedavisi i�in ikameli benzopiran t�revleri.
NZ335383A (en) Epothilone C,D,E and F for plant protection and cytostatic effects shown in kidney cells
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
MX9700885A (es) Nuevas heteroariloxazolidinonas.
MY132705A (en) Novel compounds with analgesic effect
DE3580616D1 (de) Mitomycinderivate, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
BG103096A (en) Thrombin inhibitors
DE69029231T2 (de) Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
HK1018701A1 (en) Benzopyran derivatives having leukotriene-antagonistic action.
NZ305571A (en) Cryptophycin derivatives, use in pharmaceutical compositions to inhibit mammalian cell proloferation and treat neoplasia
DE69813565D1 (de) Substituierte 3,3-diamino-2-propennitrile, ihre herstellung und verwendung
ATE267195T1 (de) Oxiranyl-triazolinthione und ihre verwendung als mikrobizide
ATE259369T1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
MX9204613A (es) Nitratos organicos, procedimientos para su preparacion y su uso en el tratamiento de enfermedades cardiovasculares
TR199900662T2 (xx) 1-Hidroksi-2-piridonlar�n seborik dermatit tedavisi amac�yla kullan�m�
TR199801485T2 (xx) Yeni 2,3 benzodiyazepin t�revleri, bu t�revlerin �retimi ve ila� olarak kullan�m�.
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
ATE284215T1 (de) Transdermale systeme enthaltend zwei wirkstoffe in getrennten abteilungen, ihre herstellungsverfahren und verwendung als arzneimittel
ATE177424T1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties